Endonovo Therapeutics (ENDV) Short Interest Ratio & Short Volume $0.0001 0.00 (-50.00%) As of 05/2/2025 12:29 PM Eastern Add Compare Share Share Short Interest Stock AnalysisChartSEC FilingsShort InterestBuy This Stock Endonovo Therapeutics Short Interest DataEndonovo Therapeutics (ENDV) has a short interest of 619,000 shares, representing 0.07% of the float (the number of shares available for trading by the public). This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 26.96 million shares to cover all short positions.Current Short Interest619,000 sharesPrevious Short Interest619,000 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$123.80Short Interest Ratio0.0 Days to CoverLast Record DateApril 15, 2025Outstanding Shares1,206,614,000 sharesShort Percent of Float0.07%Today's Trading Volume3,802,600 sharesAverage Trading Volume26,962,924 sharesToday's Volume Vs. Average14% Short Selling Endonovo Therapeutics? Sign up to receive the latest short interest report for Endonovo Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartENDV Short Interest Over TimeENDV Days to Cover Over TimeENDV Percentage of Float Shorted Over Time Endonovo Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/2025619,000 shares $123.80 No Change0.1%0 $0.00 3/31/2025619,000 shares $123.80 +54.8%0.1%0 $0.00 3/15/2025400,000 shares $80.00 +300.0%0.0%0 $0.00 2/28/2025100,000 shares $20.00 No Change0.0%0 $0.00 1/15/2025100,000 shares $40.00 +2.6%N/A0 $0.00 12/31/202497,500 shares $39.00 -2.5%N/A0 $0.00 12/15/2024100,000 shares $70.00 No ChangeN/A0 $0.00 11/30/2024100,000 shares $70.00 +15.2%N/A0 $0.00 11/15/202486,800 shares $78.12 No ChangeN/A0 $0.00 10/31/202486,800 shares $95.48 No ChangeN/A0.6 $0.00 Get the Latest News and Ratings for ENDV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Endonovo Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 10/15/202486,800 shares $78.12 -0.1%N/A0.3 $0.00 9/30/202486,900 shares $86.90 +0.1%N/A1 $0.00 9/15/202486,800 shares $121.52 No ChangeN/A0.2 $0.00 8/31/202486,800 shares $121.52 No ChangeN/A0 $0.00 8/15/202486,800 shares $86.80 No ChangeN/A0.1 $0.00 7/15/202410,000 shares $10.00 No ChangeN/A0 $0.00 4/15/20248,300 shares $26.56 No ChangeN/A0 $0.00 3/15/202410,000 shares $35.00 No ChangeN/A0.1 $0.00 2/15/202427,000 shares $118.80 +130.8%N/A0 $0.00 1/15/202421,300 shares $208.74 +309.6%N/A0 $0.01 12/31/20235,200 shares $45.24 -73.2%N/A0 $0.01 12/15/202319,400 shares $176.54 +9,600.0%N/A0 $0.01 11/30/2023200 shares $2.30 No ChangeN/A0 $0.01 10/31/20233,700 shares $51.43 No ChangeN/A0 $0.01 9/15/20231,500 shares $16.67 No ChangeN/A0 $0.01 8/31/20231,500 shares $19.05 -60.5%N/A0 $0.01 8/15/20233,800 shares $41.80 -39.7%N/A0 $0.01 7/31/20236,300 shares $69.30 No ChangeN/A0.1 $0.01 6/30/2023300 shares $4.35 No ChangeN/A0 $0.01 4/30/202341,700 shares $417.00 -3.0%N/A0.1 $0.01 4/15/202343,000 shares $712.51 +15.0%N/A0.1 $0.02 3/31/202337,400 shares $617.10 No ChangeN/A0.1 $0.02 2/15/202322,300 shares $367.95 +2,377.8%N/A0 $0.02 1/31/2023900 shares $16.92 +50.0%N/A0 $0.02 1/15/2023600 shares $9.30 No ChangeN/A0 $0.02 12/15/2022300 shares $3.93 -78.6%N/A0 $0.01 11/30/20221,400 shares $9.94 -6.7%N/A0 $0.01 11/15/20221,500 shares $13.20 No ChangeN/A0 $0.01 10/31/20221,500 shares $12.00 -76.9%N/A0 $0.01 10/15/20226,500 shares $52.00 -13.3%N/A0 $0.01Trump’s Bitcoin Reserve is No Accident… (Ad)Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new blockchain development…Just click here to get all the details on this crypto coin now 9/30/20227,500 shares $55.50 No ChangeN/A0 $0.01 8/31/202229,000 shares $216.05 +28,900.0%N/A0.1 $0.01 8/15/2022100 shares $0.83 No ChangeN/A0 $0.01 7/15/20229,000 shares $90.00 -4.3%N/A0.1 $0.01 6/30/20229,400 shares $84.60 No ChangeN/A0 $0.01 2/28/202210,900 shares $196.20 +118.0%N/A0 $0.02 2/15/20225,000 shares $85.00 No ChangeN/A0 $0.02 9/15/2021800 shares $19.20 No ChangeN/A0 $0.02 8/13/2021600 shares $16.32 -98.7%N/A0 $0.03 7/30/202147,000 shares $1,179.70 +526.7%N/A0.1 $0.03 7/15/20217,500 shares $269.25 No ChangeN/A0 $0.04 6/15/20212,900 shares $87.29 +93.3%N/A0 $0.03 5/28/20211,500 shares $50.10 -79.7%N/A0 $0.03 5/14/20217,400 shares $295.26 No ChangeN/A0 $0.04 4/15/202136,200 shares $1,086.00 No ChangeN/A0 $0.03 3/15/202115,300 shares $676.26 No ChangeN/A0 $0.04 2/26/202115,300 shares $612.00 -55.7%N/A0 $0.04 2/12/202134,500 shares $2,665.13 No ChangeN/A0 $0.08 1/15/20219,400 shares $545.20 -45.7%N/A0 $0.06 12/31/20204,900 shares $129.04 -47.9%N/A0 $0.03 12/15/20209,400 shares $366.60 -45.7%N/A0 $0.04 11/30/202017,300 shares $934.20 +116.3%N/A0.1 $0.05 11/15/20208,000 shares $510.40 No ChangeN/A0.1 $0.06 10/15/20202,800 shares $234.92 -85.1%N/A0 $0.08 9/30/202018,800 shares $1,823.60 +46.9%N/A0.1 $0.10 9/15/202012,800 shares $1,280.00 No ChangeN/A0.3 $0.10 8/14/20205,900 shares $634.25 +51.3%N/A0 $0.11 7/31/20203,900 shares $409.89 +69.6%N/A0 $0.11 7/15/20202,300 shares $207.00 -89.6%N/A0 $0.09 6/30/202022,000 shares $2,354.00 +315.1%N/A0.1 $0.11 6/15/20205,300 shares $689.00 +17.8%N/A0 $0.13 5/29/20204,500 shares $652.50 +221.4%N/A0 $0.15 5/15/20201,400 shares $192.50 -80.6%N/A0 $0.14 ENDV Short Interest - Frequently Asked Questions What is Endonovo Therapeutics' current short interest? Short interest is the volume of Endonovo Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 619,000 shares of ENDV short. 0.07% of Endonovo Therapeutics' shares are currently sold short. Learn More on Endonovo Therapeutics' current short interest. What is a good short interest percentage for Endonovo Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.07% of Endonovo Therapeutics' floating shares are currently sold short. How does Endonovo Therapeutics' short interest compare to its competitors? 0.07% of Endonovo Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "medical equipment" compare to Endonovo Therapeutics: Bluejay Diagnostics, Inc. (6.93%), Cutera, Inc. (19.35%), Arch Therapeutics, Inc. (0.15%), LogicMark, Inc. (3.29%), Remedent, Inc. (0.04%), Sharps Technology, Inc. (22.31%), RenovaCare, Inc. (0.00%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Incorporated ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management, Inc. ($3.86 billion), Capital One Financial Co. ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Co. ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks. What does it mean to sell short Endonovo Therapeutics stock? Short selling ENDV is an investing strategy that aims to generate trading profit from Endonovo Therapeutics as its price is falling. ENDV shares are trading down $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Endonovo Therapeutics? A short squeeze for Endonovo Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ENDV, which in turn drives the price of the stock up even further. How often is Endonovo Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ENDV, twice per month. The most recent reporting period available is April, 15 2025. More Short Interest Resources from MarketBeat Related Companies BJDX Short Interest CUTR Short Interest ARTH Short Interest LGMK Short Interest REMI Short Interest STSS Short Interest RCAR Short Interest AKSY Short Interest ATAO Short Interest ADLI Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:ENDV) was last updated on 5/4/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredMost traders are panicking. We’re cashing inMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon Musk is all in on these robots …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredIf you missed your chance with Tesla...Elon Musk is moments from launching a revolutionary technology some Silicon Valley insiders are calling "The F...Brownstone Research | SponsoredAI Boom Takes a Shocking Turn…What 99% of Investors are Missing in AI I believe it could be worth a fortune in the near future, yet hardl...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Endonovo Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Endonovo Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.